Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes

: Selinexor is an orally available selective inhibitor of exportin-1 that has offered a new treatment option in relapsed or refractory myeloma (RRMM) either in combination with dexamethasone (Sd) or with bortezomib and dexamethasone (SVd).

Source: Clinical Lymphoma, Myeloma and Leukemia - July 31, 2023 Category: Hematology Authors: Efstathios Kastritis, Maria Gavriatopoulou, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Nikoleta Kokkali, Evangelos Eleutherakis-Papaiakovou, Rodanthi Syrigou, Despin Tags: Original Study Source Type: research